vs
Side-by-side financial comparison of EGAIN Corp (EGAN) and ROCKWELL MEDICAL, INC. (RMTI). Click either name above to swap in a different company.
EGAIN Corp is the larger business by last-quarter revenue ($23.0M vs $18.3M, roughly 1.3× ROCKWELL MEDICAL, INC.). EGAIN Corp runs the higher net margin — 10.2% vs -3.0%, a 13.2% gap on every dollar of revenue. On growth, EGAIN Corp posted the faster year-over-year revenue change (2.6% vs -25.6%). EGAIN Corp produced more free cash flow last quarter ($9.9M vs $2.2M). Over the past eight quarters, EGAIN Corp's revenue compounded faster (1.4% CAGR vs -10.1%).
Headquartered in Sunnyvale, California, eGain Corporation helps businesses automate customer and employee experience with its AI knowledge software.
Rockwell Medical Inc. is a publicly traded pharmaceutical company based in Wixom, Michigan and founded in 1996 that focuses on development and commercialization of treatments against diseases such as end-stage renal disease (ESRD) and chronic kidney disease (CKD).
EGAN vs RMTI — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $23.0M | $18.3M |
| Net Profit | $2.3M | $-554.0K |
| Gross Margin | 73.1% | 21.1% |
| Operating Margin | 8.9% | -2.2% |
| Net Margin | 10.2% | -3.0% |
| Revenue YoY | 2.6% | -25.6% |
| Net Profit YoY | 248.1% | 26.7% |
| EPS (diluted) | $0.08 | $-0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $23.0M | $18.3M | ||
| Q3 25 | $23.5M | $15.9M | ||
| Q2 25 | $23.2M | $16.1M | ||
| Q1 25 | $21.0M | $18.9M | ||
| Q4 24 | $22.4M | $24.7M | ||
| Q3 24 | $21.8M | $28.3M | ||
| Q2 24 | $22.5M | $25.8M | ||
| Q1 24 | $22.4M | $22.7M |
| Q4 25 | $2.3M | $-554.0K | ||
| Q3 25 | $2.8M | $-1.8M | ||
| Q2 25 | $30.9M | $-1.5M | ||
| Q1 25 | $66.0K | $-1.5M | ||
| Q4 24 | $671.0K | $-756.0K | ||
| Q3 24 | $652.0K | $1.7M | ||
| Q2 24 | $1.5M | $343.0K | ||
| Q1 24 | $1.5M | $-1.7M |
| Q4 25 | 73.1% | 21.1% | ||
| Q3 25 | 75.2% | 14.3% | ||
| Q2 25 | 72.7% | 15.6% | ||
| Q1 25 | 68.0% | 16.1% | ||
| Q4 24 | 70.2% | 14.7% | ||
| Q3 24 | 69.4% | 22.0% | ||
| Q2 24 | 69.3% | 17.6% | ||
| Q1 24 | 69.3% | 13.5% |
| Q4 25 | 8.9% | -2.2% | ||
| Q3 25 | 12.1% | -9.9% | ||
| Q2 25 | 14.0% | -8.4% | ||
| Q1 25 | 0.1% | -7.2% | ||
| Q4 24 | 2.9% | -2.1% | ||
| Q3 24 | 2.3% | 6.8% | ||
| Q2 24 | 5.3% | 2.0% | ||
| Q1 24 | 4.2% | -5.8% |
| Q4 25 | 10.2% | -3.0% | ||
| Q3 25 | 12.0% | -11.0% | ||
| Q2 25 | 132.8% | -9.3% | ||
| Q1 25 | 0.3% | -8.0% | ||
| Q4 24 | 3.0% | -3.1% | ||
| Q3 24 | 3.0% | 5.9% | ||
| Q2 24 | 6.7% | 1.3% | ||
| Q1 24 | 6.7% | -7.6% |
| Q4 25 | $0.08 | $-0.01 | ||
| Q3 25 | $0.10 | $-0.05 | ||
| Q2 25 | $1.09 | $-0.05 | ||
| Q1 25 | $0.00 | $-0.04 | ||
| Q4 24 | $0.02 | $-0.02 | ||
| Q3 24 | $0.02 | $0.04 | ||
| Q2 24 | $0.05 | $0.01 | ||
| Q1 24 | $0.05 | $-0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $83.1M | $10.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $88.8M | $37.0M |
| Total Assets | $146.8M | $57.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $83.1M | $10.7M | ||
| Q3 25 | $70.9M | $13.6M | ||
| Q2 25 | $62.9M | $12.5M | ||
| Q1 25 | $68.7M | $11.4M | ||
| Q4 24 | $70.5M | $15.7M | ||
| Q3 24 | $67.2M | $12.3M | ||
| Q2 24 | $70.0M | $11.9M | ||
| Q1 24 | $83.0M | $6.6M |
| Q4 25 | $88.8M | $37.0M | ||
| Q3 25 | $83.5M | $37.0M | ||
| Q2 25 | $80.7M | $30.4M | ||
| Q1 25 | $51.6M | $31.5M | ||
| Q4 24 | $55.3M | $32.6M | ||
| Q3 24 | $55.7M | $29.1M | ||
| Q2 24 | $58.5M | $23.5M | ||
| Q1 24 | $63.9M | $20.6M |
| Q4 25 | $146.8M | $57.1M | ||
| Q3 25 | $144.6M | $57.5M | ||
| Q2 25 | $148.0M | $52.6M | ||
| Q1 25 | $106.2M | $54.0M | ||
| Q4 24 | $111.3M | $59.2M | ||
| Q3 24 | $114.9M | $57.1M | ||
| Q2 24 | $127.9M | $53.0M | ||
| Q1 24 | $120.3M | $50.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $10.1M | $2.3M |
| Free Cash FlowOCF − Capex | $9.9M | $2.2M |
| FCF MarginFCF / Revenue | 43.0% | 12.0% |
| Capex IntensityCapex / Revenue | 1.0% | 0.5% |
| Cash ConversionOCF / Net Profit | 4.33× | — |
| TTM Free Cash FlowTrailing 4 quarters | $17.6M | $-1.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $10.1M | $2.3M | ||
| Q3 25 | $10.4M | $-1.3M | ||
| Q2 25 | $-4.3M | $1.8M | ||
| Q1 25 | $2.2M | $-3.5M | ||
| Q4 24 | $6.4M | $865.0K | ||
| Q3 24 | $954.0K | $4.3M | ||
| Q2 24 | $-5.1M | $1.4M | ||
| Q1 24 | $1.7M | $-2.4M |
| Q4 25 | $9.9M | $2.2M | ||
| Q3 25 | $10.2M | $-1.5M | ||
| Q2 25 | $-4.5M | $1.7M | ||
| Q1 25 | $2.1M | $-3.5M | ||
| Q4 24 | $6.3M | $470.0K | ||
| Q3 24 | $845.0K | $4.1M | ||
| Q2 24 | $-5.2M | $1.2M | ||
| Q1 24 | $1.7M | $-2.5M |
| Q4 25 | 43.0% | 12.0% | ||
| Q3 25 | 43.4% | -9.6% | ||
| Q2 25 | -19.5% | 10.5% | ||
| Q1 25 | 10.0% | -18.8% | ||
| Q4 24 | 28.1% | 1.9% | ||
| Q3 24 | 3.9% | 14.4% | ||
| Q2 24 | -23.0% | 4.5% | ||
| Q1 24 | 7.8% | -11.1% |
| Q4 25 | 1.0% | 0.5% | ||
| Q3 25 | 1.0% | 1.4% | ||
| Q2 25 | 0.9% | 1.0% | ||
| Q1 25 | 0.5% | 0.3% | ||
| Q4 24 | 0.6% | 1.6% | ||
| Q3 24 | 0.5% | 0.7% | ||
| Q2 24 | 0.2% | 1.1% | ||
| Q1 24 | 0.1% | 0.6% |
| Q4 25 | 4.33× | — | ||
| Q3 25 | 3.70× | — | ||
| Q2 25 | -0.14× | — | ||
| Q1 25 | 33.48× | — | ||
| Q4 24 | 9.57× | — | ||
| Q3 24 | 1.46× | 2.57× | ||
| Q2 24 | -3.40× | 4.20× | ||
| Q1 24 | 1.17× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EGAN
| Transferred Over Time | $22.0M | 96% |
| Technology Service | $1.2M | 5% |
RMTI
| US | $15.9M | 87% |
| Non Us | $2.4M | 13% |
